ULTRA VOLUME LIDOCAINE is a cross-linked filling gel based on hyaluronic acid, designed to restore or increase tissue volume. Dedicated to shaping the chin, and contouring of the zygomatic line, nasal dorsum and mandible. Allows to bring back the correct proportions and shape of the face.
Despite containing molecules with the largest size of 900 μm and high volumetric capacity, it retains its plasticity and rheological properties, providing a deformationresistant and comfortable injectable filler.
The anesthetic lidocaine makes the procedure exceptionally comfortable, with little tissue dispersion.
Dermis, subcutaneous tissue
– cheek volumetrics and zygomatic line contouring
– nose shape correction
– contouring of the jawline
– chin volumetrics
The patented Hy-BRID technology is based on the use of exceptionally long and stable hyaluronic acid chains, whose concentration is invariably 24mg/ml. The difference between the individual variants lies only in the size of the molecule used. This ensures optimum plasticity of the acid, ease of injection, long-lasting effect and excellent volume.
The exceptional safety and maximum adaptability is caused by using only hyaluronic acid that meets pharmaceutical standards and its rigorous purification from the crosslinking agent BDDE, which is below detection level. This ensures that the treatment is free from the risk of allergic reactions and immunogenic or permanent swelling.
The exceptional plasticity and excellent rheological properties of the product make the injection extremely easy and precise every single time. In addition, the ergonomically designed syringe holder ensures accurate and smooth delivery.
The anesthetic lidocaine (0.3%) and thin-walled needles significantly reduce pain and increase the comfort of the procedure. The insertion process is virtually painless and tissue disruption is not felt.
The highest quality and safety of DIVES MED ULTRA LIDOCAINE is confirmed by international quality certificates ISO 13485 and ISO 9001, as well as the European Medical Certificate CE2195, issued by Emergo Europe, based in the Netherlands.